Scientists have figured out why some lung cancers become drug-resistant after initially responding to targeted therapies. In the process, they devised a new two-pronged approach that yields an effective treatment for these cancers in the laboratory and holds tremendous promise for the future of precision medicine.
from Latest Science News -- ScienceDaily https://ift.tt/2P15N5P
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment